In Brief: NDAC industry representative
This article was originally published in The Tan Sheet
Executive Summary
NDAC industry representative: FDA's Nonprescription Drugs Advisory Committee requests nominations for a non-voting panelist representing industry interests to replace Paul Roberts, MD, whose term ends May 31. The term of office is four years. Nominations and curricula vitae should be sent to: NDAC Executive Secretary Andrea Neal, Center for Drug Evaluation & Research (HFD-21), FDA, 5600 Fishers Lane, Rockville, Md., 20857...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning